WebFeb 15, 2024 · Mar 08, 2024. Galera Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates. View HTML. PDF Version. Feb 15, 2024. Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants. View HTML. PDF Version. Feb 15, 2024. WebFind detailed information on Pharmaceutical and Medicine Manufacturing companies in Brea, California, United States of America, including financial statements, sales and marketing contacts, top competitors, and firmographic insights.
About • Vera Therapeutics
WebGerbera Technologies, f ounded by a group of professionals and Digital enthusiasts with over 20 years of experience in Architecting, Designing, Developing and delivering niche … WebFind company information, contact details, financial data & company linkages for USA Gerbera Therapeutics, Inc. Taiwan Branch of Songshan District. Get the most accurate … glaser weil salary
Eureka Therapeutics - Crunchbase Company Profile & Funding
WebView the business profile and contact info for Chihming Chen, Chief Executive Officer at Gerbera Therapeutics, Inc. in California, US. Dynamic search and list-building capabilities; Real-time trigger alerts; Comprehensive company profiles; Valuable research and technology reports; WebThe City of Fawn Creek is located in the State of Kansas. Find directions to Fawn Creek, browse local businesses, landmarks, get current traffic estimates, road conditions, and … WebApr 6, 2024 · Company. Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a pipeline of therapeutic candidates to transform radiotherapy in cancer. Its lead product candidate, avasopasem manganese (GC4419), is a small molecule dismutase mimetic in … fx4 filter review